![Julie Waras Brogren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julie Waras Brogren
Directeur/Membre du Conseil chez
PILA PHARMA AB
Profil
Julie Waras Brogren currently works at Gedea Biotech AB, as Chief Executive Officer from 2026, Implexion Pharma AB, as Director, Ossiform ApS, as Director, and Pila Pharma AB, as Director from 2024.
Ms. Brogren also formerly worked at Ascelia Pharma AB, as Deputy CEO & Chief Commercial Officer from 2022 to 2023, Novo Nordisk A, as Senior Director-Launch Office, ResMed Maribo A, as Director, and Bresotec, Inc., as President from 2017 to 2019.
Ms. Brogren received her graduate degree in 2000 from EM Lyon Business School and graduate degree in 2001 from Copenhagen Business School.
Postes actifs de Julie Waras Brogren
| Sociétés | Poste | Début |
|---|---|---|
| PILA PHARMA AB | Directeur/Membre du Conseil | 01/04/2024 |
Ossiform ApS
 Ossiform ApS Medical SpecialtiesHealth Technology Develops bioactive bone substitutes | Directeur/Membre du Conseil | - |
Implexion Pharma AB
 Implexion Pharma AB Miscellaneous Commercial ServicesCommercial Services Engages in research and development on drugs | Directeur/Membre du Conseil | - |
Gedea Biotech AB
 Gedea Biotech AB Miscellaneous Commercial ServicesCommercial Services Develops a treatment for vaginal fungal infections | Directeur Général | 01/04/2026 |
Anciens postes connus de Julie Waras Brogren
| Sociétés | Poste | Fin |
|---|---|---|
Bresotec, Inc.
 Bresotec, Inc. Medical SpecialtiesHealth Technology Develops and commercializes non-invasive portable acoustic & movement recording technology for at-home diagnosis of sleep apnea | President | 01/06/2019 |
ResMed Maribo A/S
 ResMed Maribo A/S Medical/Nursing ServicesHealth Services Provides equipment and solutions for treatment and prevention within the fields of health and lifestyle | Directeur/Membre du Conseil | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
| ASCELIA PHARMA AB | Directeur Financier/CFO | - |
Formation de Julie Waras Brogren
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EM Lyon Business School
 EM Lyon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pila Pharma AB
 Pila Pharma AB BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company which develops oral anti-diabetic agents | Health Technology |
ResMed Maribo A/S
ResMed Maribo A/S Medical/Nursing ServicesHealth Services Provides equipment and solutions for treatment and prevention within the fields of health and lifestyle | Health Services |
Bresotec, Inc.
Bresotec, Inc. Medical SpecialtiesHealth Technology Develops and commercializes non-invasive portable acoustic & movement recording technology for at-home diagnosis of sleep apnea | Health Technology |
Gedea Biotech AB
Gedea Biotech AB Miscellaneous Commercial ServicesCommercial Services Develops a treatment for vaginal fungal infections | Commercial Services |
Ascelia Pharma AB
 Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Ossiform ApS
Ossiform ApS Medical SpecialtiesHealth Technology Develops bioactive bone substitutes | Health Technology |
Implexion Pharma AB
Implexion Pharma AB Miscellaneous Commercial ServicesCommercial Services Engages in research and development on drugs | Commercial Services |
